| Literature DB >> 34017078 |
Charles Ricordel1,2, Laura Chaillot1, Alice Blondel1, Jérôme Archambeau1, Florence Jouan1, Audrey Mouche1, Marie Tiercin3, Agnès Burel4, Hervé Lena1,2, Benoît Desrues1,2, Thierry Guillaudeux1,4, Rémy Pedeux5.
Abstract
ING2 (Inhibitor of Growth 2) is a tumor suppressor gene that has been implicated in critical biological functions (cell-cycle regulation, replicative senescence, DNA repair and DNA replication), most of which are recognized hallmarks of tumorigenesis occurring in the cell nucleus. As its close homolog ING1 has been recently observed in the mitochondrial compartment, we hypothesized that ING2 could also translocate into the mitochondria and be involved in new biological functions. In the present study, we demonstrate that ING2 is imported in the inner mitochondrial fraction in a redox-sensitive manner in human cells and that this mechanism is modulated by 14-3-3η protein expression. Remarkably, ING2 is necessary to maintain mitochondrial ultrastructure integrity without interfering with mitochondrial networks or polarization. We observed an interaction between ING2 and mtDNA under basal conditions. This interaction appears to be mediated by TFAM, a critical regulator of mtDNA integrity. The loss of mitochondrial ING2 does not impair mtDNA repair, replication or transcription but leads to a decrease in mitochondrial ROS production, suggesting a detrimental impact on OXPHOS activity. We finally show using multiple models that ING2 is involved in mitochondrial respiration and that its loss confers a protection against mitochondrial respiratory chain inhibition in vitro. Consequently, we propose a new tumor suppressor role for ING2 protein in the mitochondria as a metabolic shift gatekeeper during tumorigenesis.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34017078 DOI: 10.1038/s41388-021-01832-3
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867